Schizophrenia after remission of anti-NMDA receptor encephalitis

Asian J Psychiatr. 2022 Apr:70:103027. doi: 10.1016/j.ajp.2022.103027. Epub 2022 Feb 12.

Abstract

N-methyl-D-aspartate receptor (NMDAR) dysfunction is an attractive hypothesis regarding the etiology of schizophrenia. We present the unprecedented case of a woman diagnosed with schizophrenia without anti-NMDAR antibodies after history of NMDAR encephalitis. A first episode of psychosis was antibody-positive and was improved with steroid and immunoglobulin treatment. Second and third episodes were antibody-negative, each about three months postpartum (different pregnancies) and were improved with antipsychotics. Without NMDAR encephalitis-related findings, we diagnosed schizophrenia. After anti-NMDAR encephalitis, NMDAR dysfunction may decrease the threshold for the onset of psychosis. This case provides insight into NMDAR dysfunction on etiology of schizophrenia.

Keywords: NMDA receptor; NMDAR encephalitis; Schizophrenia.

Publication types

  • Case Reports

MeSH terms

  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis* / complications
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis* / diagnosis
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis* / drug therapy
  • Antipsychotic Agents* / therapeutic use
  • Female
  • Humans
  • Psychotic Disorders* / drug therapy
  • Psychotic Disorders* / etiology
  • Receptors, N-Methyl-D-Aspartate
  • Schizophrenia* / complications
  • Schizophrenia* / drug therapy

Substances

  • Antipsychotic Agents
  • Receptors, N-Methyl-D-Aspartate